Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.
Info & Links
CEO
Claude Maraoui
Headquarters
9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE, AZ 85258, UNITED STATES
Journey Medical Corporation Common Stock Statistics
Valuation Measures
Market Capitalization2
107.37M
Enterprise Value
104.70M
Enterprise Value/EBITDA(ttm)
-7.25
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
1.86
Price to Book(mrq)
9.75
Price to Cash(ytd)
28.37
Profitability
Gross Margin(ttm)
57.03%
Operating Margin(ttm)
-31.74%
Profit Margin(ttm)
-33.29%
Return on Equity(ttm)
-132.10%
Return on Invested Capital(ttm)
-62.52%
Return on Assets(ttm)
-26.90%
Income Statement
Revenue(ttm)
57.77M
Revenue Per Share(ttm)
2.77
Gross Profit(ttm)
33.11M
EBITDA(ttm)3
-14.45M
Net Income Available to Common(ttm)
-18.34M
Diluted EPS(ttm)
-0.94
Share Statistics
Beta (5Y Monthly)
1.03
52-Week Change
48.13%
S&P 500 52-Week Change
12.74%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
20.89M
Dividend Yield
0.00%
Float4
18.14M
% Held by Insiders
13.16%
% Held by Institutions
7.25%
Balance Sheet
Total Cash(mrq)
22.46M
Total Cash Per Share(mrq)
1.08
Total Debt(mrq)
19.79M
Total Debt/Equity(mrq)
181.08%
Current Ratio(mrq)
1.38%
Quick Ratio(mrq)
1.03%
Book Value Per Share(mrq)
0.53
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.55
Free Cash Flow(ytd)
-11.35M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.